Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
42.5M
-
Shares change
-
-159K
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
-$4.29M
-
Put/Call ratio
-
0
-
Number of buys
-
105
-
Number of sells
-
-89
-
Price
-
$34.67
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q4 2021
274 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q4 2021.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.5M shares
of 46.1M outstanding shares and own 92.19% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.61M shares), VANGUARD GROUP INC (5.22M shares), Paradice Investment Management LLC (3.16M shares), RGM Capital, LLC (2.93M shares), DIMENSIONAL FUND ADVISORS LP (2.09M shares), STATE STREET CORP (2.01M shares), MACQUARIE GROUP LTD (1.7M shares), GOLDMAN SACHS GROUP INC (1.61M shares), WELLINGTON MANAGEMENT GROUP LLP (1.33M shares), and Champlain Investment Partners, LLC (1.17M shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.